EIF2S1 IN URINARY EXTRACELLULAR VESICLES AS A NOVEL DIAGNOSTIC MARKER FOR BLADDER CANCER

被引：0
|
作者：
Carrasco, Raquel
Ingelmo-Torres, Mercedes
Trullas, Ramon
Roldan, Fiorella L.
Rodriguez-Carunchio, Leonardo
Figueras, Marcel
Mercader, Claudia
Padulles, Bernat
Olegario, Jasmine L.
Sureda, Joan
Alcaraz, Antonio
Izquierdo, Laura
Mengual, Lourdes
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
基金：
日本学术振兴会;
关键词：
D O I：
10.1097/01.JU.0001009500.87761.bf.04
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP15-04
引用
收藏
页码：E230 / E230
页数：1
相关论文
共 50 条
  • [41] Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer
    Yazarlou, Fatemeh
    Modarressi, Mohammad Hossein
    Mowla, Seyed Javad
    Oskooei, Vahid Kholghi
    Motevaseli, Elahe
    Tooli, Leila Farhady
    Nekoohesh, Leila
    Eghbali, Maryam
    Ghafouri-Fard, Soudeh
    Afsharpad, Mandana
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6357 - 6365
  • [42] Soluble Fas - A promising novel urinary marker for the detection of recurrent superficial bladder cancer
    Svatek, RS
    Herman, MP
    Lotan, Y
    Casella, R
    Hsieh, JT
    Sagalowsky, AI
    Shariat, SF
    CANCER, 2006, 106 (08) : 1701 - 1707
  • [43] Evaluation of plasma LC3B+extracellular vesicles as a potential novel diagnostic marker for hepatocellular carcinoma
    Chen, Yong-Qiang
    Zheng, Lu
    Zhou, Juan
    Wang, Peng
    Wang, Lu
    Zhang, Yue
    Man, Zhong-Song
    Chen, Yan-Hong
    Gu, Feng
    Niu, Guo-Ping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [44] Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease
    Marco Hadisurya
    Li Li
    Kananart Kuwaranancharoen
    Xiaofeng Wu
    Zheng-Chi Lee
    Roy N. Alcalay
    Shalini Padmanabhan
    W. Andy Tao
    Anton Iliuk
    Communications Medicine, 3
  • [45] Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease
    Hadisurya, Marco
    Li, Li
    Kuwaranancharoen, Kananart
    Wu, Xiaofeng
    Lee, Zheng-Chi
    Alcalay, Roy N.
    Padmanabhan, Shalini
    Tao, W. Andy
    Iliuk, Anton
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [46] Label-free optical redox ratio from urinary extracellular vesicles as a screening biomarker for bladder cancer
    Park, Jaena
    Kamerer, Rebecca L.
    Marjanovic, Marina
    Sorrells, Janet E.
    You, Sixian
    Barkalifa, Ronit
    Selting, Kimberly A.
    Boppart, Stephen A.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (05): : 2068 - 2083
  • [47] Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Homma, Yukio
    Fukayama, Masashi
    HISTOPATHOLOGY, 2010, 57 (06) : 885 - 892
  • [48] SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis
    Huang, Jianhua
    Li, Cheng
    Zhang, Wentao
    Yang, Fuhan
    Wang, Ruiliang
    Zhang, Junfeng
    Li, Wei
    Yao, Xudong
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [49] UHRF1 is a novel diagnostic marker of lung cancer
    Unoki, M.
    Daigo, Y.
    Koinuma, J.
    Tsuchiya, E.
    Hamamoto, R.
    Nakamura, Y.
    BRITISH JOURNAL OF CANCER, 2010, 103 (02) : 217 - 222
  • [50] UHRF1 is a novel diagnostic marker of lung cancer
    M Unoki
    Y Daigo
    J Koinuma
    E Tsuchiya
    R Hamamoto
    Y Nakamura
    British Journal of Cancer, 2010, 103 : 217 - 222
12345